CommercialBilling CodesMedium impact
COVID-19 Monoclonal Antibody Treatment and Antiviral IV Medications
Blue Cross Blue Shield of Rhode Island·RI · Emergency Medicine, Critical Care, Infectious Disease +2 more·Physician / Facility
Effective date
May 1, 2022
We identified it
Jun 19, 2026
Summary
BCBS Rhode Island has added new billing codes for COVID-19 monoclonal antibody treatments and antiviral IV medications. The policy includes several HCPCS codes (M0220, M0221, M0222, M0223) and HCPCS Q codes (Q0220, Q0221, Q0222) along with one J code (J0248) that were added throughout 2022.
Action Required
Billing team should verify these COVID-19 treatment codes are active in billing system and reference the full payment policy for specific coverage details and billing requirements. Update encounter forms to include these codes for COVID-19 monoclonal antibody and antiviral IV treatments.